Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharsight Corporation was a provider of software and services for pharmacokinetic/pharmacodynamic (PK/PD) analysis, modeling, simulation, and regulatory submissions. They collaborated with the FDA under CRADA to deliver analysis tools and raised $52.93M in funding prior to their acquisition by Tripos.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharsight Corporation.